Paper26312921
Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms.
Thomas S and 5 others. Lancet, 2015. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms. Papers, record 26312921. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26312921
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39652930 | Efficacy And Safety Of Low-Dose Methotrexate In Generalized And Recalcitrant Lichen Planus: A Retrospective Study At A Tertiary Care Center. | Dermatol Pract Concept | 2024 | https://conductscience.org/library/papers/39652930 | PubMed |
| 39650663 | Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/39650663 | PubMed |
| 39136000 | Interaction of the intestinal cytokines-JAKs-STAT3 and 5 axes with RNA N6-methyladenosine to promote chronic inflammation-induced colorectal cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/39136000 | PubMed |
| 38581063 | Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38581063 | PubMed |
| 38273295 | The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/38273295 | PubMed |
| 36845805 | Fruit fly for anticancer drug discovery and repurposing. | Ann Med Surg (Lond) | 2023 | https://conductscience.org/library/papers/36845805 | PubMed |
| 36713518 | Harnessing the immune system in the treatment of cutaneous T cell lymphomas. | Front Oncol | 2022 | https://conductscience.org/library/papers/36713518 | PubMed |
| 36354684 | The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset. | Curr Issues Mol Biol | 2022 | https://conductscience.org/library/papers/36354684 | PubMed |
| 36320927 | The Anti-Psoriatic Efficacy and Safety Profile of Topical and Intralesional Methotrexate: A Literature Review. | Clin Cosmet Investig Dermatol | 2022 | https://conductscience.org/library/papers/36320927 | PubMed |
| 35219333 | Plasma interleukin-23 and circulating IL-17A+IFNγ+ ex-Th17 cells predict opposing outcomes of anti-TNF therapy in rheumatoid arthritis. | Arthritis Res Ther | 2022 | https://conductscience.org/library/papers/35219333 | PubMed |
| 34824210 | The JAK/STAT signaling pathway: from bench to clinic. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34824210 | PubMed |
| 33082164 | Candidate drug replacements for quinacrine in cutaneous lupus erythematosus. | Lupus Sci Med | 2020 | https://conductscience.org/library/papers/33082164 | PubMed |
| 31572192 | Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31572192 | PubMed |
| 30558204 | Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30558204 | PubMed |
| 29854765 | Learning on the Fly: The Interplay between Caspases and Cancer. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29854765 | PubMed |
| 29670920 | Methotrexate Combined with 4-Hydroperoxycyclophosphamide Downregulates Multidrug-Resistance P-Glycoprotein Expression Induced by Methotrexate in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via the JAK2/STAT3 Pathway. | J Immunol Res | 2018 | https://conductscience.org/library/papers/29670920 | PubMed |
| 29620612 | Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection. | Transplantation | 2018 | https://conductscience.org/library/papers/29620612 | PubMed |
| 29108266 | The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy. | Oncotarget | 2017 | https://conductscience.org/library/papers/29108266 | PubMed |
| 27278657 | JAK3-STAT pathway blocking benefits in experimental lupus nephritis. | Arthritis Res Ther | 2016 | https://conductscience.org/library/papers/27278657 | PubMed |
| 27143038 | QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics. | BMC Bioinformatics | 2016 | https://conductscience.org/library/papers/27143038 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| JAK1 | 3716 | PubTator's text mining | https://conductscience.org/library/genes/3716 | NCBI Gene |
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26312921
GET https://conductscience.org/api/papers/v1/26312921/authors